These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 11171813)

  • 1. Helicobacter pylori associated gastric B cell MALT lymphoma: predictive factors for regression.
    Morgner A; Bayerdörffer E; Neubauer A; Stolte M
    Gut; 2001 Mar; 48(3):290-2. PubMed ID: 11171813
    [No Abstract]   [Full Text] [Related]  

  • 2. Helicobacter pylori eradication therapy in primary high-grade gastric MALT lymphoma.
    Fischbach W
    Gastroenterology; 2002 Jul; 123(1):393. PubMed ID: 12105882
    [No Abstract]   [Full Text] [Related]  

  • 3. Predictive factors for regression of gastric MALT lymphoma after anti-Helicobacter pylori treatment.
    Ruskoné-Fourmestraux A; Lavergne A; Aegerter PH; Megraud F; Palazzo L; de Mascarel A; Molina T; Rambaud JL
    Gut; 2001 Mar; 48(3):297-303. PubMed ID: 11171816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Gastric MALT lymphoma, a malignancy potentially curable by eradication of Helicobacter pylori].
    Delchier JC
    Gastroenterol Clin Biol; 2003 Mar; 27(3 Pt 2):453-8. PubMed ID: 12700502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of vitaflor to eradicate Helicobacter pylori in treatment of MALT-lymphoma of the stomach].
    Gershanovich ML; Petrov LN; Dobritsa VP; Kalinovskiĭ VP; Nikitina MV
    Vopr Onkol; 2006; 52(6):696-8. PubMed ID: 17338252
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment for gastric mucosa-associated lymphoid tissue (MALT) lymphoma.
    Maeda T; Niitsu N
    Intern Med; 2006; 45(6):353-4. PubMed ID: 16617183
    [No Abstract]   [Full Text] [Related]  

  • 7. Helicobacter pylori Eradication Therapy, the Reasonable First Line Therapy for Gastric Mucosa-Associated Lymphoid Tissue Lymphoma Irrespective of Infection Status and Disease Stages.
    Cheung DY
    Gut Liver; 2016 Sep; 10(5):659-60. PubMed ID: 27563015
    [No Abstract]   [Full Text] [Related]  

  • 8. Second complete remission of Helicobacter pylori negative gastric MALT lymphoma following antibiotic treatment.
    Troch M; Püspök A; Streubel B; Chott A; Raderer M
    Leuk Lymphoma; 2007 Jan; 48(1):204-6. PubMed ID: 17325871
    [No Abstract]   [Full Text] [Related]  

  • 9. Characteristics of Helicobacter pylori-positive and Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma and their influence on clinical outcome.
    Choi YJ; Kim N; Paik JH; Kim JM; Lee SH; Park YS; Hwang JH; Kim JW; Jeong SH; Lee DH; Jung HC
    Helicobacter; 2013 Jun; 18(3):197-205. PubMed ID: 23305046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term follow-up of gastric MALT lymphoma treated by eradication of H. pylori with antibodies.
    Isaacson PG; Diss TC; Wotherspoon AC; Barbazza R; De Boni M; Doglioni C
    Gastroenterology; 1999 Sep; 117(3):750-1. PubMed ID: 10490369
    [No Abstract]   [Full Text] [Related]  

  • 11. Translocation t(11;18)(q21;q21) is not predictive of response to chemotherapy with 2CdA in patients with gastric MALT lymphoma.
    Streubel B; Ye H; Du MQ; Isaacson PG; Chott A; Raderer M
    Oncology; 2004; 66(6):476-80. PubMed ID: 15452377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of Helicobacter pylori eradication in the treatment of diffuse large B-cell and marginal zone lymphomas of the stomach.
    Ferreri AJ; Govi S; Ponzoni M
    Curr Opin Oncol; 2013 Sep; 25(5):470-9. PubMed ID: 23942292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Our experience in Helicobacter pylori infection and gastric MALToma.
    Losacco T; Cagiano R; Bottalico L; Carlaio RG; Prejbeanu R; Vermesan H; Dragulescu SI; Vermesan D; Motoc A; Santacroce L
    Clin Ter; 2008; 159(4):239-42. PubMed ID: 18776980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term clinical outcome of gastric MALT lymphoma after eradication of Helicobacter pylori: a multicentre cohort follow-up study of 420 patients in Japan.
    Nakamura S; Sugiyama T; Matsumoto T; Iijima K; Ono S; Tajika M; Tari A; Kitadai Y; Matsumoto H; Nagaya T; Kamoshida T; Watanabe N; Chiba T; Origasa H; Asaka M;
    Gut; 2012 Apr; 61(4):507-13. PubMed ID: 21890816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphomas: A review.
    Asano N; Iijima K; Koike T; Imatani A; Shimosegawa T
    World J Gastroenterol; 2015 Jul; 21(26):8014-20. PubMed ID: 26185372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review article: common misconceptions in the management of Helicobacter pylori-associated gastric MALT-lymphoma.
    Gisbert JP; Calvet X
    Aliment Pharmacol Ther; 2011 Nov; 34(9):1047-62. PubMed ID: 21919927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of gastric marginal zone lymphoma of MALT type.
    Stathis A; Bertoni F; Zucca E
    Expert Opin Pharmacother; 2010 Sep; 11(13):2141-52. PubMed ID: 20586708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consecutive regression of concurrent laryngeal and gastric MALT lymphoma after anti-Helicobacter pylori therapy.
    Caletti G; Togliani T; Fusaroli P; Sabattini E; Khodadadian E; Gamberi B; Gobbi M; Pileri S
    Gastroenterology; 2003 Feb; 124(2):537-43. PubMed ID: 12557157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Helicobacter pylori infection in gastric extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT) lymphoma: a re-evaluation.
    Sena Teixeira Mendes L; D Attygalle A; C Wotherspoon A
    Gut; 2014 Sep; 63(9):1526-7. PubMed ID: 24951256
    [No Abstract]   [Full Text] [Related]  

  • 20. Management and long-term follow-up of early stage H. pylori-associated gastric MALT-lymphoma in clinical practice: an Italian, multicentre study.
    Andriani A; Miedico A; Tedeschi L; Patti C; Di Raimondo F; Leone M; Schinocca L; Romanelli A; Bonanno G; Linea C; Giustini M; Hassan C; Cottone M; Zullo A
    Dig Liver Dis; 2009 Jul; 41(7):467-73. PubMed ID: 18945654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.